James Vaughn

2018

In 2018, James Vaughn earned a total compensation of $1.6M as Chief U.S. Commercial Officer at Genomic Health, a 12% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$258,780
Option Awards$662,011
Salary$416,200
Stock Awards$225,496
Total$1,562,487

Vaughn received $662K in option awards, accounting for 42% of the total pay in 2018.

Vaughn also received $258.8K in non-equity incentive plan, $416.2K in salary and $225.5K in stock awards.

Rankings

In 2018, James Vaughn's compensation ranked 6,960th out of 14,244 executives tracked by ExecPay. In other words, Vaughn earned more than 51.1% of executives.

ClassificationRankingPercentile
All
6,960
out of 14,244
51st
Division
Services
1,320
out of 2,377
45th
Major group
Health Services
103
out of 218
53rd
Industry group
Medical And Dental Laboratories
22
out of 76
71st
Industry
Medical Laboratories
22
out of 76
71st
Source: SEC filing on April 25, 2019.

Vaughn's colleagues

We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2018.

2018

Kimberly Popovits

Genomic Health

Chief Executive Officer

2018

Frederic Pla

Genomic Health

Chief Operating Officer

2018

G Cole

Genomic Health

Chief Financial Officer

2018

Steven Shak

Genomic Health

Chief Scientific Officer

News

You may also like